Atlas Arteria Limited
Atlas Arteria Limited
Your view on MAQAF
Overview
What the company does, where it operates, and who runs it.
About Atlas Arteria Limited
- Industry
- Industrial - Infrastructure Operations
- Sector
- Industrials
- CEO
- Hugh Wehby DipInvRel
- Headquarters
- 180 Flinders Street, Melbourne, VIC, AU
- Industry
- Industrial - Infrastructure Operations
- Sector
- Industrials
- CEO
- Hugh Wehby DipInvRel
- Headquarters
- 180 Flinders Street, Melbourne, VIC, AU
Atlas Arteria Limited owns, develops, and operates toll roads. It holds a 13.4% interest in 22-kilometer toll road investors partnership II (TRIP II), the concessionaire for Dulles Greenway toll road located in Virginia, the United States.
The company was formerly known as Macquarie Atlas Roads Limited and changed its name to Atlas Arteria Limited in May 2018. Atlas Arteria Limited was incorporated in 2009 and is based in Melbourne, Australia.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Atlas Arteria Limited, and the rating behind it. MAQAF last traded at $3.68, 23.5× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Atlas Arteria Limited. Starting points for Atlas Arteria Limited: P/E 23.5, EPS $0.19, beta 0.46 — an Industrial - Infrastructure Operations name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Atlas Arteria Limited. Atlas Arteria Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Atlas Arteria Limited. Trailing twelve-month EPS for Atlas Arteria Limited stands at $0.19. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Atlas Arteria Limited. Atlas Arteria Limited has reported as a listed company since 2010. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Atlas Arteria Limited valued side by side against its closest peers. Atlas Arteria Limited is measured against Industrial - Infrastructure Operations peers within the Industrials sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Atlas Arteria Limited, and how their positions are changing. At a $5.34B market value, institutional positions materially move Atlas Arteria Limited's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Atlas Arteria Limited executives and directors. Shares of Atlas Arteria Limited have traded between $2.69 and $3.68 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Atlas Arteria Limited. Atlas Arteria Limited is a $5.34B Industrials company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Atlas Arteria Limited. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Atlas Arteria Limited. Coverage tracks Atlas Arteria Limited within Industrial - Infrastructure Operations (Industrials). Press releases and market coverage, newest first.